tirzepatide classification TIRZEPATIDE.pptx Tirzepatide a novel anti diabetic

It has been established that TRZ inhibits A-induced BIR and associated synaptic dysfunction, memory dysfunction, and cognitive impairment by restoring the PI3 K/AKT/GSK3 signaling pathway in the AD mouse model (Guo et al

In the matched expanded populations, the mean age ranged from 59.2 to 69.2 years, 50.455.8% were female and the mean body mass index (BMI) ranged from 34.5 to 38.7 kg m 2

Low NAD+ levels are associated with metabolic syndrome, obesity, and type 2 diabetes

Unlike older medications, tirzepatide targets both receptors, reducing hunger, improving insulin sensitivity, and potentially increasing calorie burning

Conclusion Semaglutide and Tirzepatide represent two important approaches to incretin-based research